Transforming Egypt's Healthcare System Project: Purchasing virus C drugs to Naser institute treatment unit phase (1)

Last update: Dec 8, 2020 Last update: 08 Dec, 2020

Details

Locations: Egypt

Start Date: May 17, 2020

End Date: Aug 17, 2020

Value: EGP 1,564,000.000

Sectors:

Health

Categories: Goods

Funding Agencies:

World Bank HQ (USA)

Date posted: Dec 8, 2020

Associated funding

Associated experts

Description

Project ID: P167000
Project title: Transforming Egypt's Healthcare System Project
Bid/Contract Reference No: EG-MOHP-164742-GO-RFQ
Scope of Contract: This is a fixed dose combination drug. Each tablet contains 400 mg of Sofosbuvir and 100 mg of Velpatasvir.
Duration of Contract 3 Month(s)

Reference — Transforming Egypt's Healthcare System Project: Purchasing virus C drugs to Naser institute treatment unit phase (1) — for Egypt presented by World Bank HQ (USA) (goods), budget is EGP 1,564,000.000, in Health sector. Reference — Transforming Egypt's Healthcare System Project: Purchasing virus C drugs to Naser institute treatment unit phase (1) — for Egypt presented by World Bank HQ (USA) (goods), budget is EGP 1,564,000.000, in Health sector. Reference — Transforming Egypt's Healthcare System Project: Purchasing virus C drugs to Naser institute treatment unit phase (1) — for Egypt presented by World Bank HQ (USA) (goods), budget ...

Want to unlock full information?

Member-only information. Become a member to access projects awards, find the right consortia partners, subcontractors and more.